Johnson & Johnson (JNJ) Tops Q4 EPS by 2c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Johnson & Johnson (JNJ) PT Lowered to $145 at Raymond James
January 23, 2019 7:38 AM ESTRaymond James analyst Jayson Bedford lowered the price target on Johnson & Johnson (NYSE: JNJ) to $145.00 (from $149.00) while maintaining a Outperform rating.
... MoreJohnson & Johnson (JNJ) PT Lowered to $144 at RBC Capital
January 23, 2019 6:53 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Johnson & Johnson (NYSE: JNJ) to $144.00 (from $155.00) while maintaining a Outperform rating.
Novarro notes management has set conservative 2019 guidance. As such, he expects the 'beat and raises' to continue.
... More


